Clinical trials: Pericarditis
Recurrent Pericarditis
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)
Patients with recurrent pericarditis who are refractory or intolerant to current therapeutic management options or who require long-term administration of corticosteroids to control their disease are particularly challenging to…
- Trial name
- NCT05494788
- Testing
- CardiolRx
- Where
- 8 sites in United States
- Volunteers
- 27 people
- Sponsor
- Cardiol Therapeutics Inc.
Recurrent Pericarditis
Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis
The primary objective of this study was to assess the efficacy of rilonacept treatment in participants with recurrent pericarditis.
- Trial name
- RHAPSODY (NCT03737110)
- Testing
- Rilonacept
- Where
- 21 sites in United States, Australia and 2 more
- Volunteers
- 86 people
- Sponsor
- Kiniksa Pharmaceuticals (UK), Ltd.
Recurrent Pericarditis
A Pilot Study of KPL-914 in Recurrent Pericarditis
The purpose of this study is to assess the preliminary efficacy and safety of KPL-914 treatment in participants with recurrent pericarditis.
- Trial name
- NCT03980522
- Testing
- KPL-914
- Where
- 14 sites in United States
- Volunteers
- 26 people
- Sponsor
- Kiniksa Pharmaceuticals (UK), Ltd.
Acute Pericarditis
Treatment of Acute Pericarditis With Anakinra
The goal of this study is to determine the safety and efficacy of anakinra for the treatment of acute pericarditis when initiated within 6 hours of diagnosis and continued for 3 or 7 days. 1.
- Trial name
- NCT03224585
- Testing
- Anakinra
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Virginia Commonwealth University